Hexagon Nutrition came to market through an IPO that opened on 5 June 2026 and closed on 9 June 2026, and the shares listed on 12 June 2026 on BSE, NSE. The price band was ₹42 to ₹45 per share and one lot was 333 shares, so the minimum application was ₹14,985. The issue size was ₹138.87 crore. The whole issue was an offer for sale, so the proceeds went to the selling shareholders rather than the company.
Kfin Technologies Ltd was the registrar to the issue, and Cumulative Capital Pvt.Ltd., Catalyst Capital Partners Pvt.Ltd were the lead managers.
As of 9 June 2026.
| Day |
|---|
| 1 |
| 2 |
| 3 |
Incorporated in the year 1993, Hexagon Nutrition Ltd. is a research-led nutrition company. The business is involved in the development and production of products in areas of micronutrient premixes, branded wellness and clinical nutrition, therapeutic formulations, and ready-to-use food products. It has three manufacturing units based in India located in Nasik (Maharashtra), Chennai (Tamil Nadu), and Thoothukudi (Tamil Nadu) and one more unit abroad in Tashkent, Uzbekistan.
The two Indian units are located in Special Economic Zone areas in Chennai and Thoothukudi and offer benefits like easy access to port and duty-free imports. The product range can be segmented as follows:
Products for branded wellness and clinical nutrition (B2C) Formulations of premix (B2B2C) ESG initiatives – Ready-to-Use Foods (RUFs) & Micronutrient Powders (MNPs) Hexagon Nutrition has a PAN-India omni-channel distribution system that includes retail pharmacies, hospital chains, online portals, e-pharmacy sites, and own branded sites like Pentasure, Obesigo, Pediagold, and Nutrone. It has over 358 distributors across India, including 8 multi-state distributors for domestic distribution.
The firm has opened overseas branches in South Africa, Uzbekistan, and Hong Kong to facilitate its international operations. Its products have been sold to over 75 nations located in Asia, Africa, Europe, and South America during fiscal years 2023 to 2025. Hexagon Nutrition has two research & development centers located in Nasik and Chennai with the assistance of a team of 12 specialists. As of March 31, 2026, Hexagon had 527 employees.
As described in the offer document.
| Metric | 31-Dec-25 | 31-Mar-25 | 31-Mar-24 | 31-Mar-23 |
|---|
Hexagon Nutrition Limited has finalised its anchor investor allocation on June 4, 2026, raising ₹41.66 crore from 5 institutional investors at an anchor price of ₹45 per share. The anchor book comprises a total of 92,57,696 equity shares allocated across domestic and foreign investors. Bandhan Small Cap Fund received the largest allocation at 28.82%, followed by Ampersand Growth Opportunities Fund Scheme-I at 24.00% and CP Capital Limited at 23.16%.
Visionary Value Fund and Innovative Vision Fund each received 12.01% of the anchor portion.
Arun Purushottam Kelkar, Subhash Purushottam Kelkar, Vikram Arun Kelkar, Nikhil Arun Kelka. Promoter holding 89.41% before the issue and 64.29% after.
Work out the listing gain for this IPO
If the retail portion is not fully subscribed, every valid application is allotted in full. If it is oversubscribed, SEBI's rules require that as many applicants as possible receive at least one lot, so the shares are allotted by a computerised lottery across all valid applications, one lot each, until the retail portion is exhausted. Applying for more lots does not improve your chance in a lottery; it only increases what you receive if the issue is under-subscribed.
The basis of allotment document, published by the registrar on the allotment date, states the ratio: for example, one applicant in seven received one lot.
Allotment status is published by the registrar on its website, searchable by PAN, application number or demat account, and also on the exchange's website. Allotted shares are credited to the demat account the day before listing, and blocked money for unsuccessful applications is released the same day. The Rupix app can check allotment status by PAN once the registrar publishes it.
Shares list within three working days of the issue closing. On listing day the exchanges run a special pre-open session from nine o'clock, during which orders are collected and an opening price is discovered from them; trading in the share begins after that, usually around ten. The opening price is the listing price that appears on this page once the issue has listed, and the listing gain or loss is the difference between it and the issue price.
For a mainboard issue, the share then trades in the normal way with the exchange's price band for a new listing. For an SME issue, shares trade in lots rather than one at a time, and the market can be thin, so selling on listing day is not always possible at the opening price. Capital gains on shares sold within a year of allotment are short-term and taxed at the short-term rate.
Hexagon Nutrition IPO was a ₹138.87 crore book-built issue, made up entirely of an offer for sale. It was priced at ₹42–₹45 per share with a lot size of 333 shares (₹14,985). The IPO was open from June 5 to June 9, 2026 and was subscribed 53.68x. Shares listed on BSE and NSE on June 12, 2026 at ₹48.25, a 7.2% premium to the issue price of ₹45. Kfin Technologies Ltd. is the registrar. Cumulative Capital Pvt. Ltd.
and Catalyst Capital Partners Pvt. Ltd. are the book running lead managers.
The price band of Hexagon Nutrition IPO is ₹42 to ₹45 per share.
The lot size of Hexagon Nutrition IPO is 333 shares.
The minimum investment for Hexagon Nutrition IPO is approximately ₹14,985 based on the upper price band.
The allotment date of Hexagon Nutrition IPO is Jun 10, 2026.
Hexagon Nutrition IPO's final recorded GMP before listing was ₹2 per share (a 4% premium over the ₹45 upper price band). The shares listed at ₹48.25. GMP is unofficial and does not forecast or guarantee the actual listing price.
Hexagon Nutrition IPO listed on Jun 12, 2026. It was issued at ₹48.25(NSE) and is currently around ₹58.00 as on 2-Nov-2026 3:30 PM, which is approximately 28.9% versus issue price. The 52-week high is ₹78.25.
You can check Hexagon Nutrition IPO allotment status on the registrar or stock exchange websites using your PAN or application number after allotment. You can also check the Hexagon Nutrition IPO allotment status on Rupix for quick and easy access.
₹42 to ₹45 per share, against a face value of ₹1. Most applicants bid at the cut-off price, the top of the band, so that the application was valid whatever price the issuer finally fixed.
One lot was 333 shares, and every application had to be a whole number of lots. At the top of the band that made the minimum application ₹14,985.
₹14,985, for one lot of 333 shares at the top of the price band. The amount was blocked in the applicant's bank account through ASBA or a UPI mandate while the issue was open, and released on the allotment date to applicants who were not allotted shares.
It opened on 5 June 2026 and closed on 9 June 2026.
The basis of allotment was published on 10 June 2026 by Kfin Technologies Ltd, and allotted shares were credited to demat accounts before listing.
The shares listed on 12 June 2026 on BSE, NSE.
The issue size was ₹138.87 crore. The offer for sale was 3,08,59,704 shares (aggregating up to ₹138.87 crore).